Amgen Inc. Repayments of Long-Term Debt
Amgen Inc. (AMGN) reported Repayments of Long-Term Debt of $833.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-05
- Amgen Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Amgen Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $833.00M, a 66.68% decline year-over-year.
- Amgen Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $0.00.
- Amgen Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $1.50B, a 31.82% decline year-over-year.
- Amgen Inc. repayments of long-term debt for fiscal 2025 was $5.00B, a 38.89% increase from fiscal 2024.
- Amgen Inc. repayments of long-term debt for fiscal 2024 was $3.60B, a 147.59% increase from fiscal 2023.
- Amgen Inc. repayments of long-term debt for fiscal 2023 was $1.45B.
- Amgen Inc. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $833.00M 10-Q · filed 2026-08-05 | $833.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.33B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $833.00M 10-Q · filed 2026-05-01 | $833.00M derived: sum of 2 quarters · filed 2026-05-01 | $2.33B derived: sum of 3 quarters · filed 2026-05-01 | $3.33B derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.50B derived: sum of 2 quarters · filed 2026-02-13 | $2.50B derived: sum of 3 quarters · filed 2026-02-13 | $5.00B 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.50B 10-Q · filed 2025-11-05 | $2.50B derived: sum of 2 quarters · filed 2025-11-05 | $5.00B 10-Q · filed 2025-11-05 | $5.00B derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-06-30 | $1.00B 10-Q · filed 2025-08-06 | $3.50B 10-Q · filed 2026-08-05 | $3.50B derived: sum of 3 quarters · filed 2026-05-01 | $5.70B derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-03-31 | $2.50B 10-Q · filed 2026-05-01 | $2.50B derived: sum of 2 quarters · filed 2026-05-01 | $4.70B derived: sum of 3 quarters · filed 2026-05-01 | $6.10B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.20B derived: sum of 2 quarters · filed 2026-02-13 | $3.60B derived: sum of 3 quarters · filed 2026-02-13 | $3.60B 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.20B 10-Q · filed 2025-11-05 | $3.60B derived: sum of 2 quarters · filed 2025-11-05 | $3.60B 10-Q · filed 2025-11-05 | $3.60B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $1.40B 10-Q · filed 2025-08-06 | $1.40B 10-Q · filed 2025-08-06 | $1.40B derived: sum of 3 quarters · filed 2026-02-13 | $2.15B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $750.00M derived: sum of 3 quarters · filed 2026-02-13 | $750.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $750.00M derived: sum of 2 quarters · filed 2026-02-13 | $750.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.45B 10-K · filed 2026-02-13 |
| 2023-09-30 | $750.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $750.00M derived: sum of 2 quarters · filed 2024-10-31 | $1.45B 10-Q · filed 2024-10-31 | $1.45B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $704.00M 10-Q · filed 2024-08-07 | $704.00M derived: sum of 3 quarters · filed 2025-02-14 | $704.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $704.00M 10-Q · filed 2024-05-03 | $704.00M derived: sum of 2 quarters · filed 2025-02-14 | $704.00M derived: sum of 3 quarters · filed 2025-02-14 | $704.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-14 | $0.00 10-K · filed 2025-02-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-10-31 | $0.00 10-Q · filed 2023-10-31 | $4.15B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $4.15B derived: sum of 3 quarters · filed 2024-02-14 | $4.15B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-04-28 | $4.15B derived: sum of 2 quarters · filed 2024-02-14 | $4.15B derived: sum of 3 quarters · filed 2024-02-14 | $4.15B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $4.15B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $4.15B derived: sum of 2 quarters · filed 2024-02-14 | $4.15B derived: sum of 3 quarters · filed 2024-02-14 | $4.15B 10-K · filed 2024-02-14 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | $1.45B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $0.00 10-Q · filed 2021-08-04 | $1.45B derived: sum of 3 quarters · filed 2023-02-09 | $1.45B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-28 | $1.45B derived: sum of 2 quarters · filed 2023-02-09 | $1.45B derived: sum of 3 quarters · filed 2023-02-09 | $3.20B derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $1.45B derived: sum of 2 quarters · filed 2023-02-09 | $3.20B derived: sum of 3 quarters · filed 2023-02-09 | $6.45B 10-K · filed 2023-02-09 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.75B derived: sum of 2 quarters · filed 2021-11-03 | $5.00B 10-Q · filed 2021-11-03 | $5.00B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $1.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.00B 10-Q · filed 2021-08-04 | $5.00B derived: sum of 3 quarters · filed 2022-02-16 | $5.86B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $3.25B 10-Q · filed 2021-04-28 | $3.25B derived: sum of 2 quarters · filed 2022-02-16 | $4.11B derived: sum of 3 quarters · filed 2022-02-16 | $6.76B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $864.00M derived: sum of 2 quarters · filed 2022-02-16 | $3.51B derived: sum of 3 quarters · filed 2022-02-16 | $4.51B 10-K · filed 2022-02-16 |
| 2019-09-30 | $864.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $3.51B derived: sum of 2 quarters · filed 2020-10-29 | $4.51B 10-Q · filed 2020-10-29 | $5.13B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $2.65B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $3.65B 10-Q · filed 2020-07-29 | $4.27B derived: sum of 3 quarters · filed 2021-02-09 | $4.27B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $1.00B 10-Q · filed 2020-05-01 | $1.62B derived: sum of 2 quarters · filed 2021-02-09 | $1.62B derived: sum of 3 quarters · filed 2021-02-09 | $2.12B derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $621.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $621.00M derived: sum of 2 quarters · filed 2021-02-09 | $1.12B derived: sum of 3 quarters · filed 2021-02-09 | $1.12B 10-K · filed 2021-02-09 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $500.00M derived: sum of 2 quarters · filed 2019-10-30 | $500.00M 10-Q · filed 2019-10-30 | $500.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $500.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $500.00M 10-Q · filed 2019-07-31 | $500.00M derived: sum of 3 quarters · filed 2020-02-12 | $500.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2020-02-12 | $0.00 derived: sum of 3 quarters · filed 2020-02-12 | $3.80B derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $0.00 derived: sum of 2 quarters · filed 2020-02-12 | $3.80B derived: sum of 3 quarters · filed 2020-02-12 | $4.41B 10-K · filed 2020-02-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $3.80B derived: sum of 2 quarters · filed 2018-10-31 | $4.41B 10-Q · filed 2018-10-31 | $5.41B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $3.80B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $4.41B 10-Q · filed 2018-07-27 | $5.41B derived: sum of 3 quarters · filed 2019-02-13 | $7.13B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $605.00M 10-Q · filed 2018-04-25 | $1.60B derived: sum of 2 quarters · filed 2019-02-13 | $3.33B derived: sum of 3 quarters · filed 2019-02-13 | $4.21B derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $2.73B derived: sum of 2 quarters · filed 2019-02-13 | $3.60B derived: sum of 3 quarters · filed 2019-02-13 | $3.73B 10-K · filed 2019-02-13 |
| 2016-09-30 | $1.73B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $2.60B derived: sum of 2 quarters · filed 2017-10-26 | $2.73B 10-Q · filed 2017-10-26 | $2.85B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $875.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $1.00B 10-Q · filed 2017-07-26 | $1.13B derived: sum of 3 quarters · filed 2018-02-13 | $1.25B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $125.00M 10-Q · filed 2017-04-27 | $250.00M derived: sum of 2 quarters · filed 2018-02-13 | $375.00M derived: sum of 3 quarters · filed 2018-02-13 | $2.40B derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $250.00M derived: sum of 2 quarters · filed 2018-02-13 | $2.27B derived: sum of 3 quarters · filed 2018-02-13 | $2.40B 10-K · filed 2018-02-13 |
| 2015-09-30 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $2.15B derived: sum of 2 quarters · filed 2016-10-28 | $2.27B 10-Q · filed 2016-10-28 | $4.40B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $2.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $2.15B 10-Q · filed 2016-07-29 | $4.28B derived: sum of 3 quarters · filed 2017-02-14 | $4.40B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $125.00M 10-Q · filed 2016-05-02 | $2.25B derived: sum of 2 quarters · filed 2017-02-14 | $2.38B derived: sum of 3 quarters · filed 2017-02-14 | $5.61B derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.25B derived: sum of 2 quarters · filed 2017-02-14 | $5.48B derived: sum of 3 quarters · filed 2017-02-14 | $5.61B 10-K · filed 2017-02-14 |
| 2014-09-30 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $3.35B derived: sum of 2 quarters · filed 2015-11-02 | $3.48B 10-Q · filed 2015-11-02 | $4.35B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $3.23B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.35B 10-Q · filed 2015-08-05 | $4.23B derived: sum of 3 quarters · filed 2016-10-31 | $4.23B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $125.00M 10-Q · filed 2015-04-27 | $996.00M derived: sum of 2 quarters · filed 2016-10-31 | $996.00M derived: sum of 3 quarters · filed 2016-10-31 | $996.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $871.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $871.00M derived: sum of 2 quarters · filed 2016-10-31 | $871.00M derived: sum of 3 quarters · filed 2016-10-31 | $3.37B 8-K · filed 2016-10-31 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $0.00 derived: sum of 2 quarters · filed 2014-10-29 | $2.50B 10-Q · filed 2014-10-29 | $2.52B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $2.50B 10-Q · filed 2014-08-05 | $2.52B derived: sum of 3 quarters · filed 2015-02-19 | $2.52B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $2.50B 10-Q · filed 2014-04-30 | $2.52B derived: sum of 2 quarters · filed 2015-02-19 | $2.52B derived: sum of 3 quarters · filed 2015-02-19 | $2.54B derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $21.00M derived: sum of 2 quarters · filed 2015-02-19 | $39.00M derived: sum of 3 quarters · filed 2015-02-19 | $123.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $18.00M derived: sum of 2 quarters · filed 2013-10-29 | $102.00M 10-Q · filed 2013-10-29 | $102.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $102.00M 10-Q · filed 2013-08-06 | $102.00M derived: sum of 3 quarters · filed 2014-02-24 | $102.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $84.00M 10-Q · filed 2013-05-03 | $84.00M derived: sum of 2 quarters · filed 2014-02-24 | $84.00M derived: sum of 3 quarters · filed 2014-02-24 | $84.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $0.00 derived: sum of 2 quarters · filed 2014-02-24 | $0.00 derived: sum of 3 quarters · filed 2014-02-24 | $2.50B 10-K · filed 2014-02-24 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $2.50B 10-Q · filed 2012-11-06 | $2.50B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.50B 10-Q · filed 2012-08-08 | $2.50B derived: sum of 3 quarters · filed 2013-02-27 | $2.50B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $2.50B 10-Q · filed 2012-05-08 | $2.50B derived: sum of 2 quarters · filed 2013-02-27 | $2.50B derived: sum of 3 quarters · filed 2013-02-27 | $2.50B derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | $0.00 10-K · filed 2013-02-27 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | $1.00B derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $0.00 10-Q · filed 2011-08-08 | $1.00B derived: sum of 3 quarters · filed 2012-02-29 | |
| 2010-03-31 | $0.00 10-Q · filed 2011-05-10 | $1.00B derived: sum of 2 quarters · filed 2012-02-29 | ||
| 2009-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $1.00B 10-K · filed 2012-02-29 | ||
| 2009-09-30 | $0.00 10-Q · filed 2009-11-06 | |||
| 2008-12-31 | $1.00B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $2.00B 10-K · filed 2011-02-25 | ||
| 2008-09-30 | $1.00B 10-Q · filed 2009-11-06 | |||
| 2007-12-31 | $1.84B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |